Related references
Note: Only part of the references are listed.Effect of modular conjugation strategy for N-acetylgalactosamine-targeted antisense oligonucleotides
Tsuyoshi Yamamoto et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2020)
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Sarah Bajan et al.
CELLS (2020)
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
Alexandre J. Debacker et al.
MOLECULAR THERAPY (2020)
In vivoandin vitrostudies of antisense oligonucleotides - a review
Anna Kilanowska et al.
RSC ADVANCES (2020)
Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
Thomas Treiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
GalNAc Conjugation Attenuates the Cytotoxicity of Antisense Oligonucleotide Drugs in Renal Tubular Cells
Sabine Sewing et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Metabolism and Disposition of Volanesorsen, a 2′-O-(2 methoxyethyl) Antisense Oligonucleotide, Across Species
Noah Post et al.
DRUG METABOLISM AND DISPOSITION (2019)
Highly efficient silencing of microRNA by heteroduplex oligonucleotides
Kotaro Yoshioka et al.
NUCLEIC ACIDS RESEARCH (2019)
Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
Maja M. Janas et al.
NATURE COMMUNICATIONS (2018)
Cholesterol-GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides
Fumito Wada et al.
NUCLEIC ACID THERAPEUTICS (2018)
Immune Phenotype and Function of Natural Killer and T Cells in Chronic Hepatitis C Patients Who Received a Single Dose of Anti-MicroRNA-122, RG-101
Femke Stelma et al.
HEPATOLOGY (2017)
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
Sebastien A. Burel et al.
NUCLEIC ACIDS RESEARCH (2016)
Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides
Tsuyoshi Yamamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Sensitive and specific miRNA detection method using SplintR Ligase
Jingmin Jin et al.
NUCLEIC ACIDS RESEARCH (2016)
siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
Shigeo Matsuda et al.
ACS CHEMICAL BIOLOGY (2015)
Efficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense Oligonucleotides
Michael E. Ostergaard et al.
BIOCONJUGATE CHEMISTRY (2015)
Hepatocyte-Specific Delivery of siRNAs Conjugated to Novel Non-nucleosidic Trivalent N-Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
Kallanthottathil G. Rajeev et al.
CHEMBIOCHEM (2015)
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents
Volker Baumann et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Role of miR-122 and lipid metabolism in HCV infection
Takasuke Fukuhara et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Pharmacological Inhibition of a MicroRNA Family in Nonhuman Primates by a Seed-Targeting 8-Mer AntimiR
Veerle Rottiers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Hepatotoxic Potential of Therapeutic Oligonucleotides Can Be Predicted from Their Sequence and Modification Pattern
Peter H. Hagedorn et al.
NUCLEIC ACID THERAPEUTICS (2013)
The discovery approaches and detection methods of microRNAs
Yong Huang et al.
MOLECULAR BIOLOGY REPORTS (2011)
Silencing of microRNA families by seed-targeting tiny LNAs
Susanna Obad et al.
NATURE GENETICS (2011)
The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug Targets
Ailbhe M. McDermott et al.
PHARMACEUTICAL RESEARCH (2011)
MicroRNA-122 Modulates the Rhythmic Expression Profile of the Circadian Deadenylase Nocturnin in Mouse Liver
Shihoko Kojima et al.
PLOS ONE (2010)
Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome
Catherine L. Jopling et al.
CELL HOST & MICROBE (2008)
microRNA-122 stimulates translation of hepatitis C virus RNA
Jura Inga Henke et al.
EMBO JOURNAL (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver
Joacim Elmen et al.
NUCLEIC ACIDS RESEARCH (2008)
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
Eric E. Swayze et al.
NUCLEIC ACIDS RESEARCH (2007)
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
C Esau et al.
CELL METABOLISM (2006)
Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302)
Tanya A. Watanabe et al.
OLIGONUCLEOTIDES (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Share Paper
